BOM:526139 (India)
Â
Shs Dematerialised
₹
6.97
(+4.03%)
Nov 27
Business Description
Transgene Biotek Ltd
ISIN : INE773D01018
Share Class Description:
BOM:526139: Shs DematerialisedCompare
Compare
Traded in other countries / regions
526139.India170942.Luxembourg IPO Date
2001-05-07Description
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and different products. The Company is operating only in one segment of Bulk Drugs. The group's product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the provision of medical diagnostic services, research and development, and sales of products.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.08 | |||||
| Debt-to-Equity | 1.29 | |||||
| Debt-to-EBITDA | -178.73 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.28 | |||||
| Beneish M-Score | 0.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.1 | |||||
| 3-Year EBITDA Growth Rate | -18.1 | |||||
| 3-Year EPS without NRI Growth Rate | 59.7 | |||||
| 3-Year Book Growth Rate | -21.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.59 | |||||
| 9-Day RSI | 57.22 | |||||
| 14-Day RSI | 51.09 | |||||
| 6-1 Month Momentum % | 6.27 | |||||
| 12-1 Month Momentum % | -25.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 77.14 | |||||
| Quick Ratio | 77.14 | |||||
| Days Inventory | 30964.17 | |||||
| Days Sales Outstanding | 519786.09 | |||||
| Days Payable | 136297.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.26 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.8 | |||||
| Operating Margin % | -377.39 | |||||
| Net Margin % | -130.5 | |||||
| FCF Margin % | 2.33 | |||||
| ROE % | -2.37 | |||||
| ROA % | -0.18 | |||||
| ROIC % | -0.5 | |||||
| ROC (Joel Greenblatt) % | -0.06 | |||||
| ROCE % | -0.13 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 1340 | |||||
| PS Ratio | 232.33 | |||||
| PB Ratio | 4.88 | |||||
| Price-to-Tangible-Book | 12.23 | |||||
| Price-to-Free-Cash-Flow | 6970 | |||||
| Price-to-Operating-Cash-Flow | 6970 | |||||
| EV-to-EBIT | -391.32 | |||||
| EV-to-EBITDA | -854.79 | |||||
| EV-to-Revenue | 337.68 | |||||
| EV-to-FCF | 14068.13 | |||||
| Price-to-Projected-FCF | 9.55 | |||||
| Price-to-Net-Current-Asset-Value | 0.07 | |||||
| Earnings Yield (Greenblatt) % | -0.25 | |||||
| FCF Yield % | 0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Transgene Biotek Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1.977 | ||
| EPS (TTM) (₹) | -0.04 | ||
| Beta | 2.17 | ||
| Volatility % | 111.74 | ||
| 14-Day RSI | 51.09 | ||
| 14-Day ATR (₹) | 0.45651 | ||
| 20-Day SMA (₹) | 6.7725 | ||
| 12-1 Month Momentum % | -25.41 | ||
| 52-Week Range (₹) | 5.79 - 12.46 | ||
| Shares Outstanding (Mil) | 75.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Transgene Biotek Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Transgene Biotek Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Transgene Biotek Ltd Frequently Asked Questions
What is Transgene Biotek Ltd(BOM:526139)'s stock price today?
The current price of BOM:526139 is ₹6.97. The 52 week high of BOM:526139 is ₹12.46 and 52 week low is ₹5.79.
When is next earnings date of Transgene Biotek Ltd(BOM:526139)?
The next earnings date of Transgene Biotek Ltd(BOM:526139) is .
Does Transgene Biotek Ltd(BOM:526139) pay dividends? If so, how much?
Transgene Biotek Ltd(BOM:526139) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers